J Geller

1.1k total citations
29 papers, 879 citations indexed

About

J Geller is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, J Geller has authored 29 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 16 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in J Geller's work include Hormonal and reproductive studies (14 papers), Prostate Cancer Treatment and Research (14 papers) and Sexual Differentiation and Disorders (7 papers). J Geller is often cited by papers focused on Hormonal and reproductive studies (14 papers), Prostate Cancer Treatment and Research (14 papers) and Sexual Differentiation and Disorders (7 papers). J Geller collaborates with scholars based in United States, India and Japan. J Geller's co-authors include Jacobo Albert, John D. McConnell, E Stoner, J D Wilson, Frances Pappas, Fredrick W. George, Gen Niwayama, Debra Lopez, Suzanne Geller and J. Lester Gabrilove and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

J Geller

29 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Geller United States 15 425 417 247 210 120 29 879
Tongzu Liu China 14 29 0.1× 263 0.6× 106 0.4× 320 1.5× 28 0.2× 48 704
Su Jin Kim South Korea 15 28 0.1× 68 0.2× 54 0.2× 295 1.4× 58 0.5× 38 635
John A. McLane United States 15 83 0.2× 54 0.1× 22 0.1× 270 1.3× 115 1.0× 21 775
Gerasimos P. Vandoros Greece 14 40 0.1× 111 0.3× 17 0.1× 353 1.7× 211 1.8× 24 797
Nadia Idres France 9 54 0.1× 33 0.1× 179 0.7× 408 1.9× 129 1.1× 9 760
Egbert Schulze Germany 20 361 0.8× 57 0.1× 32 0.1× 510 2.4× 133 1.1× 36 1.0k
Valentina Martineti Italy 13 61 0.1× 34 0.1× 8 0.0× 196 0.9× 230 1.9× 21 610
U Seiffert Germany 11 107 0.3× 47 0.1× 7 0.0× 143 0.7× 16 0.1× 29 377
Günther Konwalinka Austria 13 12 0.0× 39 0.1× 59 0.2× 317 1.5× 32 0.3× 26 669
Е. Л. Лушникова Russia 10 30 0.1× 55 0.1× 21 0.1× 157 0.7× 20 0.2× 140 475

Countries citing papers authored by J Geller

Since Specialization
Citations

This map shows the geographic impact of J Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Geller more than expected).

Fields of papers citing papers by J Geller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Geller. The network helps show where J Geller may publish in the future.

Co-authorship network of co-authors of J Geller

This figure shows the co-authorship network connecting the top 25 collaborators of J Geller. A scholar is included among the top collaborators of J Geller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Geller. J Geller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burton, D. W., J Geller, Meng Yang, et al.. (2004). Monitoring of skeletal progression of prostate cancer by GFP imaging, X‐ray, and serum OPG and PTHrP. The Prostate. 62(3). 275–281. 23 indexed citations
2.
Miljković, Djordje, et al.. (1998). New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH. The Prostate. 37(2). 126–129. 10 indexed citations
3.
Tan, Yuying, Qing Han, Mingxu Xu, et al.. (1998). Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients.. PubMed. 17(5B). 3857–60. 70 indexed citations
4.
Geller, J. (1995). Five-Year Follow-Up of Patientswith Benign ProstaticHyperplasia Treated withFinasteride. European Urology. 27(4). 267–273. 22 indexed citations
5.
Geller, J. (1995). Prolonging survival in metastatic prostate cancer: the case for adrenal androgens--overview and summary of therapeutic controversies in prostatic cancer.. The Journal of Clinical Endocrinology & Metabolism. 80(4). 1074–1078. 7 indexed citations
6.
Geller, J. (1995). Clinical review: 67: Approach to chemoprevention of prostate cancer.. The Journal of Clinical Endocrinology & Metabolism. 80(3). 717–719. 12 indexed citations
7.
Denis, L., Herbert Lepor, Joseph B. Dowd, et al.. (1992). Panel IX: Alternatives to surgery for benign prostatic hyperplasia. Cancer. 70(S1). 374–378. 5 indexed citations
8.
McConnell, John D., J D Wilson, Fredrick W. George, et al.. (1992). Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.. The Journal of Clinical Endocrinology & Metabolism. 74(3). 505–508. 264 indexed citations
9.
Geller, J, et al.. (1987). RELATIONSHIP BETWEEN HUMAN PROSTATIC EPITHELIAL CELL PROTEIN SYNTHESIS AND TISSUE DIHYDROTESTOSTERONE LEVEL. Clinical Endocrinology. 26(2). 155–161. 28 indexed citations
10.
11.
Geller, J, et al.. (1983). Comparison of various hormonal therapies for prostatic carcinoma.. PubMed. 10(4 Suppl 4). 34–41. 27 indexed citations
12.
Geller, J. (1982). [Endocrine pathogenesis of benign prostatic hypertrophy].. PubMed. 103(5-6). 118–21. 1 indexed citations
13.
Geller, J, et al.. (1979). Some current problems relating to androgen receptor methodology.. PubMed. 33. 97–102. 3 indexed citations
14.
Reid, Lynne, et al.. (1978). Androgen-dependent human prostatic carcinoma tumor line in nude mice. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 151. 1 indexed citations
15.
Geller, J, et al.. (1977). Using antiandrogen therapy in benign prostatic hypertrophy.. PubMed. 32(4). 63–7, 71. 3 indexed citations
16.
Geller, J, Jacobo Albert, Debra Lopez, Suzanne Geller, & Gen Niwayama. (1976). COMPARISON OF ANDROGEN METABOLITES IN BENIGN PROSTATIC HYPERTROPHY (BPH) AND NORMAL PROSTATE. The Journal of Clinical Endocrinology & Metabolism. 43(3). 686–688. 112 indexed citations
17.
Geller, J, et al.. (1965). HUMAN BENIGN PROSTATIC HYPERPLASIA.. PubMed. 79. 270–83. 83 indexed citations
18.
Geller, J, Herbert Volk, & M. Lewin. (1961). Objective remission of metastatic breast carcinoma in a male who recieved 17-alpha hydroxy progesterone caproate (delalutin).. PubMed. 14. 77–81. 5 indexed citations
19.
Geller, J, et al.. (1958). Muscular dystrophy: evaluation of adrenal cortical function and influence of corticotropin, cortisone and testosterone.. PubMed. 7(2). 97–107. 4 indexed citations
20.
Geller, J, J. Lester Gabrilove, & L. J. Soffer. (1957). RESPONSE OF PLASMA 17,21-DIHYDROXY-20-KETOSTEROIDS TO REPOSITORY CORTICOTROPIN. The Journal of Clinical Endocrinology & Metabolism. 17(3). 390–394. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tongzu Liu Breakdown of academic impact, for papers by Su Jin Kim Breakdown of academic impact, for papers by John A. McLane Breakdown of academic impact, for papers by Gerasimos P. Vandoros Breakdown of academic impact, for papers by Nadia Idres Breakdown of academic impact, for papers by Egbert Schulze Breakdown of academic impact, for papers by Valentina Martineti Breakdown of academic impact, for papers by U Seiffert Breakdown of academic impact, for papers by Günther Konwalinka Breakdown of academic impact, for papers by Е. Л. Лушникова
Rankless by CCL
2026